Fidelity Investments’s Ocular Therapeutix OCUL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$277M Buy
32,653,764
+868,159
+3% +$8.27M 0.01% 722
2025
Q4
$386M Sell
31,785,605
-29
-0% -$352 0.02% 603
2025
Q3
$372M Buy
31,785,634
+12,177,463
+62% +$146M 0.02% 611
2025
Q2
$182M Buy
19,608,171
+18,666,877
+1,983% +$146M 0.01% 860
2025
Q1
$6.9M Buy
941,294
+480,847
+104% +$3.7M ﹤0.01% 2042
2024
Q4
$3.93M Buy
460,447
+26,078
+6% +$254K ﹤0.01% 2241
2024
Q3
$3.78M Buy
434,369
+428,335
+7,099% +$3.53M ﹤0.01% 2207
2024
Q2
$41.3K Sell
6,034
-63,058
-91% -$389K ﹤0.01% 3709
2024
Q1
$629K Sell
69,092
-28
-0% -$199 ﹤0.01% 2650
2023
Q4
$308K Buy
69,120
+340
+0.5% +$1K ﹤0.01% 2818
2023
Q3
$216K Buy
68,780
+62,793
+1,049% +$257K ﹤0.01% 2872
2023
Q2
$30.9K Buy
5,987
+1,236
+26% +$7.35K ﹤0.01% 3664
2023
Q1
$25K Buy
4,751
+2,175
+84% +$10.3K ﹤0.01% 3752
2022
Q4
$7.24K Sell
2,576
-2,459
-49% -$8.14K ﹤0.01% 4130
2022
Q3
$21K Buy
5,035
+1,626
+48% +$8.19K ﹤0.01% 3835
2022
Q2
$14K Buy
3,409
+1,271
+59% +$4.8K ﹤0.01% 4002
2022
Q1
$11K Buy
+2,138
New +$11.9K ﹤0.01% 4227
2021
Q4
Sell
-1,135,345
Closed -$11.4M 4757
2021
Q3
$11.4M Sell
1,135,345
-63,592
-5% -$714K ﹤0.01% 2079
2021
Q2
$17M Buy
1,198,937
+1,014,069
+549% +$15.4M ﹤0.01% 1904
2021
Q1
$3.03M Sell
184,868
-6
-0% -$116 ﹤0.01% 2376
2020
Q4
$3.83M Buy
184,874
+141,221
+324% +$2.1M ﹤0.01% 2242
2020
Q3
$332K Sell
43,653
-122,800
-74% -$1.02M ﹤0.01% 2607
2020
Q2
$1.39M Hold
166,453
﹤0.01% 2347
2020
Q1
$824K Hold
166,453
﹤0.01% 2362
2019
Q4
$657K Sell
166,453
-118,600
-42% -$412K ﹤0.01% 2458
2019
Q3
$867K Sell
285,053
-403,595
-59% -$1.8M ﹤0.01% 2447
2019
Q2
$3.03M Sell
688,648
-1,151,651
-63% -$4.26M ﹤0.01% 2233
2019
Q1
$7.31M Sell
1,840,299
-193,300
-10% -$777K ﹤0.01% 1968
2018
Q4
$8.09M Sell
2,033,599
-266,800
-12% -$1.47M ﹤0.01% 1873
2018
Q3
$15.8M Sell
2,300,399
-939,049
-29% -$5.89M ﹤0.01% 1786
2018
Q2
$21.9M Hold
3,239,448
﹤0.01% 1682
2018
Q1
$21.1M Buy
3,239,448
+2,074,949
+178% +$11.7M ﹤0.01% 1700
2017
Q4
$5.18M Sell
1,164,499
-117,300
-9% -$599K ﹤0.01% 2162
2017
Q3
$7.92M Sell
1,281,799
-42,500
-3% -$274K ﹤0.01% 2019
2017
Q2
$12.3M Sell
1,324,299
-41,400
-3% -$401K ﹤0.01% 1872
2017
Q1
$12.7M Sell
1,365,699
-1,255,069
-48% -$10.5M ﹤0.01% 1874
2016
Q4
$21.9M Sell
2,620,768
-894,162
-25% -$6.94M ﹤0.01% 1639
2016
Q3
$24.1M Sell
3,514,930
-196,622
-5% -$1.2M ﹤0.01% 1594
2016
Q2
$18.4M Buy
3,711,552
+531,995
+17% +$5.27M ﹤0.01% 1717
2016
Q1
$30.7M Sell
3,179,557
-530,571
-14% -$4.02M ﹤0.01% 1461
2015
Q4
$34.8M Buy
3,710,128
+717,501
+24% +$7.75M ﹤0.01% 1412
2015
Q3
$42.1M Buy
2,992,627
+243,606
+9% +$4.89M 0.01% 1320
2015
Q2
$57.8M Buy
2,749,021
+1,379,257
+101% +$34.2M 0.01% 1276
2015
Q1
$57.5M Buy
1,369,764
+1,091,512
+392% +$35.9M 0.01% 1272
2014
Q4
$6.54M Buy
+278,252
New +$4.68M ﹤0.01% 2141

Other funds holding OCUL